Neurogene Inc Cash Flow-to-Debt Ratio
Neurogene Inc cash flow-to-debt ratio. Neurogene Inc (NGNE) has a Cash Flow-to-Debt Ratio of -1.03x as of March 2026, meaning its operating cash flow of $-26.12 Million could theoretically repay -1% of its total liabilities ($25.36 Million) in one year. Check Neurogene Inc (NGNE) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Neurogene Inc (2011–2025)
Cash flow-to-debt ratio of Neurogene Inc from 2011 to 2025. Historical debt coverage capacity for Neurogene Inc across 15 annual periods. Check Neurogene Inc (NGNE) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Neurogene Inc Cash Flow-to-Debt Ratio by Year (2011–2025)
Neurogene Inc cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Neurogene Inc. For the full cash flow conversion analysis, see Neurogene Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.25x | $-77.17 Million | $23.72 Million | ▼ -16.9% |
| 2024 | -2.78x | $-70.60 Million | $25.36 Million | ▼ -97.9% |
| 2023 | -1.41x | $-51.42 Million | $36.55 Million | ▲ +71.7% |
| 2022 | -4.97x | $-52.82 Million | $10.64 Million | ▼ -1969.3% |
| 2021 | -0.24x | $-46.40 Million | $193.36 Million | ▲ +81.2% |
| 2020 | -1.27x | $-24.57 Million | $19.30 Million | ▲ +55.9% |
| 2019 | -2.88x | $-15.39 Million | $5.34 Million | ▲ +54.8% |
| 2018 | -6.38x | $-31.58 Million | $4.95 Million | ▼ -63.4% |
| 2017 | -3.91x | $-44.72 Million | $11.44 Million | ▼ -25.6% |
| 2016 | -3.11x | $-30.23 Million | $9.72 Million | ▲ +24.4% |
| 2015 | -4.12x | $-20.27 Million | $4.92 Million | ▼ -22.0% |
| 2014 | -3.38x | $-17.81 Million | $5.28 Million | ▼ -218.2% |
| 2013 | -1.06x | $-7.94 Million | $7.48 Million | ▲ +78.5% |
| 2012 | -4.93x | $-7.23 Million | $1.47 Million | ▲ +34.8% |
| 2011 | -7.55x | $-9.80 Million | $1.30 Million | — |